Actavis UK: Actavis UK raised drug prices 12,000 pct, watchdog finds
Dec 16 (Reuters) - Drug maker Actavis UK broke competition law by raising prices of hydrocortisone tablets by more than 12,000 percent, Britain's competition watchdog said in a provisional ruling on Friday.
Read full article »
Actavis develops, manufactures and commercializes generic, over-the-counter medicines and biologic products.
Read more